Evolution of Laboratory Diagnostics for Cryptococcosis and Missing Links to Optimize Diagnosis and Outcomes in Resource-Constrained Settings.

cryptococcal meningitis cryptococcosis fungal diagnostics laboratory diagnostics resource-constrained setting

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 03 05 2024
accepted: 23 08 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: epublish

Résumé

Cryptococcal meningitis is one of the leading causes of death in sub-Saharan Africa among patients with advanced HIV disease. Early diagnosis is crucial in improving treatment outcomes. Despite advances and the availability of modern and point-of-care diagnostics for cryptococcosis, gaps still exist in resource-constrained settings, leading to unfavorable treatment outcomes. Here, we review the current outstanding issues or missing links that need to be filled to optimize the diagnosis of cryptococcosis in resource-constrained settings to improve treatment outcomes. We highlight the evolution of cryptococcosis diagnostics; the roles of early fungicidal activity, cryptococcal antigen titers, antifungal susceptibility testing, and therapeutic drug monitoring; and the missing links to optimize diagnosis and outcomes, including practical recommendations.

Identifiants

pubmed: 39282635
doi: 10.1093/ofid/ofae487
pii: ofae487
pmc: PMC11398909
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

ofae487

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors: No reported conflicts.

Auteurs

Richard Kwizera (R)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Tadeo K Kiiza (TK)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Andrew Akampurira (A)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Medical Microbiology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.

Sarah Kimuda (S)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Timothy Mugabi (T)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

David B Meya (DB)

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Department of Medicine, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda.

Classifications MeSH